Filing search / Phathom Pharmaceuticals, Inc. / "Oversight"

Search information

Phathom Pharmaceuticals, Inc.

Companies

"Oversight"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

20 results

Newest first Best match first

10-K

2024 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report

requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance … regulatory oversight by the EMA, the European Commission and/or the competent regulatory authorities of the member states. The holder of a MA must

6 Mar 25

8:05am

10-K/A

2023 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report (amended)

an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight

14 Jun 24

4:05pm

DEF 14A

PHAT Phathom Pharmaceuticals, Inc.

Definitive proxy

oversight of the Takeda team bringing vonoprazan to the Japanese market in seven indications contributed to our board of directors’ conclusion that he should … to determine an optimal board leadership structure to ensure the independent oversight of management as the company continues to grow. We separate the roles

12 Apr 24

4:03pm

10-K

2023 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report

and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws … States, both MA holders and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission

7 Mar 24

4:01pm

DEF 14A

PHAT Phathom Pharmaceuticals, Inc.

Definitive proxy

business and prior oversight of the Takeda team bringing vonoprazan to the Japanese market in seven indications contributed to our board of directors … . Our board of directors recognizes that it is important to determine an optimal board leadership structure to ensure the independent oversight

13 Apr 23

4:03pm

12 Apr 22

8:30am

10-K

vpdx sy61

Annual report

1 Mar 22

4:16pm

DEF 14A

d8rbc ed4ch

Definitive proxy

6 Apr 21

8:30am

10-K

iwbo9

Annual report

30 Mar 21

4:56pm

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Prospectus supplement with pricing info

IPO registration (amended)

Draft registration statement (amended)

Draft registration statement

12:00am

Filing search / Phathom Pharmaceuticals, Inc. / "Oversight"

20 results

Top filers

Top filing types

Recent filing years